Ipilimumab/Nivolumab Regimen

Preferred Label : Ipilimumab/Nivolumab Regimen;

NCIt synonyms : Ipilimumab Nivolumab; Ipilimumab Plus Nivolumab; Nivolumab/Ipilimumab; Ipilimumab/Nivolumab; Ipilimumab-Nivolumab; Ipilimumab-Nivolumab Regimen;

NCIt related terms : Ipilimumab and Nivolumab;

NCIt definition : A regimen consisting of ipilimumab and nivolumab that can be used for the treatment of bone cancer, kidney cancer, colorectal cancer, melanoma, non-small cell lung cancer (NSCLC), and malignant pleural/peritoneal mesothelioma.;

NCI Metathesaurus CUI : CL555273;

Codes from synonyms : 11084;

Details

Origin ID

C154272;

UMLS CUI

C4727545;

Est indiqué pour
- Colorectal cancer metastatic [MedDRA Preferred Term]
- Malignant Pleural Mesothelioma [MeSH concept]
- Metastatic Lung Non-Small Cell Carcinoma [NCIt concept]
- Microsatellite instability-high colorectal cancer (disorder) [SNOMED CT concept]
- Unresectable Pleural Malignant Mesothelioma [NCIt concept]
- carcinoma, non-small-cell lung [MeSH Descriptor]
- clear cell renal cell carcinoma [MeSH concept]
Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Ipilimumab [NCIt concept]
- Nivolumab [NCIt concept]
concept_is_in_subset
- HemOnc Regimen Terminology [NCIt concept]
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients